Daily Trades
- Dylan Jovine
We’ve had such outrageous gains this year, it’s time to sell off some losers that just haven’t delivered the wins I hoped.
- Dylan Jovine
Lots to discuss today, so I’m going to take them one at a time.
- Dylan Jovine
Always pay close attention to oncology companies nearing potentially, game-changing treatments. Look at Exelixis (EXEL), for example.
deal of the month
Categories
Dylan Jovine | AI Boom or Bubble? Why $325B in Spending Could Trigger a Crash!
Dylan Jovine | AI Spending Hits $300B: The Next Big Winner.. And It's NOT NVIDIA
Dylan Jovine | Eli Lilly’s $20B Breakthrough: Gold Rush in Cancer Therapy
Recent posts
Tags
Connect with Us
- Dylan Jovine
We’ve had such outrageous gains this year, it’s time to sell off some losers that just haven’t delivered the wins I hoped.
- Dylan Jovine
Lots to discuss today, so I’m going to take them one at a time.
- Dylan Jovine
Always pay close attention to oncology companies nearing potentially, game-changing treatments. Look at Exelixis (EXEL), for example.
Get FREE Daily Stock Tips
Join and receive market insider stock picks, trade alerts and unique investing insights
By clicking the "Subscribe" button you are accepting our Terms of Use and Privacy Policy.